State Street Corp Incyte Corp Call Options Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INCY
# of Institutions
617Shares Held
215MCall Options Held
366KPut Options Held
445K-
Baker Bros. Advisors LP New York, NY36.2MShares$2.14 Billion26.1% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$1.37 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$1.34 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA15.4MShares$910 Million0.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.68MShares$335 Million0.51% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $13.1B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...